Tango Therapeutics Inc

NAS:TNGX (USA)  
$ 7.61 +0.69 (+9.97%) 10:09 PM EST
At Loss
P/B:
2.79
Market Cap:
$ 813.10M
Enterprise V:
$ 434.01M
Volume:
548.62K
Avg Vol (2M):
519.16K
Volume:
548.62K
At Loss
Avg Vol (2M):
519.16K

Business Description

Tango Therapeutics Inc
NAICS : 325412 SIC : 2834
ISIN : US87583X1090
Description
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.
Name Current Vs Industry Vs History
Cash-To-Debt 8.99
Equity-to-Asset 0.65
Debt-to-Equity 0.15
Debt-to-EBITDA -0.31
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.82
Distress
Grey
Safe
Beneish M-Score -2.07
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 67.38
9-Day RSI 60.04
14-Day RSI 55.19
6-1 Month Momentum % -25.21
12-1 Month Momentum % 101.27

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 8.23
Quick Ratio 8.23
Cash Ratio 8.03
Days Sales Outstanding 19.61

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -5.3
Shareholder Yield % -6.75

Financials (Next Earnings Date:2024-08-07 Est.)

TNGX's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:TNGX

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Tango Therapeutics Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 37.232
EPS (TTM) ($) -1.11
Beta 0
Volatility % 129.2
14-Day RSI 55.19
14-Day ATR ($) 0.481097
20-Day SMA ($) 7.207
12-1 Month Momentum % 101.27
52-Week Range ($) 2.88 - 13.03
Shares Outstanding (Mil) 106.85

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Tango Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Tango Therapeutics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Tango Therapeutics Inc Frequently Asked Questions

What is Tango Therapeutics Inc(TNGX)'s stock price today?
The current price of TNGX is $7.61. The 52 week high of TNGX is $13.03 and 52 week low is $2.88.
When is next earnings date of Tango Therapeutics Inc(TNGX)?
The next earnings date of Tango Therapeutics Inc(TNGX) is 2024-08-07 Est..
Does Tango Therapeutics Inc(TNGX) pay dividends? If so, how much?
Tango Therapeutics Inc(TNGX) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1